Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1993 |
| gptkbp:ATCCode |
N03AX12
|
| gptkbp:chemicalFormula |
C9H17NO2
|
| gptkbp:contraindication |
hypersensitivity to gabapentin
|
| gptkbp:drugClass |
analgesic
anticonvulsant |
| gptkbp:eliminationHalfLife |
5-7 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:form |
gptkb:tablet
capsule oral solution |
| gptkbp:genericName |
gptkb:gabapentin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neurontin
|
| gptkbp:indication |
gptkb:restless_legs_syndrome
peripheral neuropathy fibromyalgia hot flashes partial seizures |
| gptkbp:legalStatus |
prescription only
Rx-only (US) POM (UK) Rx-only (Canada) S4 (Australia) |
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
modulates voltage-gated calcium channels
|
| gptkbp:metabolism |
not significantly metabolized
|
| gptkbp:offLabelUse |
bipolar disorder
insomnia anxiety disorders migraine prevention alcohol withdrawal |
| gptkbp:pregnancyCategory |
C (US)
B3 (Australia) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
fatigue drowsiness ataxia peripheral edema |
| gptkbp:synonym |
gptkb:gabapentin
|
| gptkbp:usedFor |
epilepsy
peripheral neuropathy postherpetic neuralgia |
| gptkbp:bfsParent |
gptkb:gabapentin
|
| gptkbp:bfsLayer |
6
|